BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for X4 Pharmaceuticals, Inc. (XFOR)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for X4 Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-13
5:51 pm
Sale		2022-12-3113GX4 Pharmaceuticals, Inc.
XFOR		BIOTECHNOLOGY VALUE FUND L P75,280
1.900%		-25,642decrease
(-25.41%)		Filing
2022-02-14
1:02 pm
Purchase		2021-12-3113GX4 Pharmaceuticals, Inc.
XFOR		BIOTECHNOLOGY VALUE FUND L P100,922
9.990%		43,602increase
(+76.07%)		Filing
2021-02-12
8:57 pm
Purchase		2020-12-3113GX4 Pharmaceuticals, Inc.
XFOR		BIOTECHNOLOGY VALUE FUND L P57,321
9.990%		1,971increase
(+3.56%)		Filing